Mayo Medical Laboratories
Mayo Medical Laboratories said this week that it has begun offering mass spec-based serum thyroglobulin testing using SISCAPA technology.
The Mayo Medical Laboratories will now offer Sequenom's MaterniT21 Plus test to patients at high risk for fetal chromosome abnormalities.
Dx Focus: Mayo Offers BioTheranostics's CancerType ID; LabCorp Sells Qiagen's Therascreen KRAS
Premium
BioTheranostics said this week that Mayo Clinic and Mayo Medical Laboratories will offer the company's CancerType ID molecular cancer classification test to aid in the management of patients with metastatic cancer.
Mayo to Offer BioTheranostics' Molecular Cancer Classification Test
NEW YORK (GenomeWeb News) – Mayo Clinic and Mayo Medical Laboratories will offer BioTheranostics' CancerType ID molecular cancer classification test under a deal announced today.
The new test will be based on real-time PCR using fluorescence resonance energy transfer probes for detection.
Jul 18, 2011
Mayo Clinic Licenses TB Technology from Qiagen
Jun 23, 2011